List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 139 studies with search of:   "Tetanus"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
21 Active, not recruiting Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis;   Haemophilus Influenzae Type B
Interventions: Biological: PEDIACEL® and Prevenar®;   Biological: Infanrix®-IPV+Hib and Prevenar®
22 Active, not recruiting Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®
Conditions: Meningococcal Meningitis;   Tetanus;   Diphtheria;   Pertussis;   Poliomyelitis
Interventions: Biological: Polysaccharide Diphtheria Toxoid Conjugate Vaccine;   Biological: Polysaccharide Diphtheria Toxoid Conjugate Vaccine;   Biological: Polysaccharide Diphtheria Toxoid Conjugate Vaccine
23 Active, not recruiting Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar®
Conditions: Diphtheria;   Pertussis;   Polio;   Hepatitis B;   Tetanus
Interventions: Biological: Hybrid 5 component DTaP, Vero IPV, Hep B and PRP-OMPC;   Biological: Hybrid 5 component DTaP, Vero IPV, Hep B and PRP-OMPC;   Biological: Hybrid 5 component DTaP, Vero IPV, Hep B and PRP-OMPC
24 Completed Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Intervention: Biological: Boostrix-Polio
25 Completed Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™
Conditions: Diphtheria;   Tetanus;   Haemophilus Infection;   Pertussis;   Polio
Interventions: Biological: Liquid HCPDT-mIPV to reconstitute lyophilized ActHIB®: PRP-T;   Biological: Liquid HCPDT-mIPV to reconstitute lyophilized ActHIB®: PRP-T
26 Active, not recruiting Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Haemophilus Influenzae Type B
Interventions: Biological: DTaP-HB-PRP~T vaccine;   Biological: Tritanrix-HepB/Hib™
27 Active, not recruiting Immunogenicity and Safety of Pentaxim™ in an Indian Population
Conditions: Diphtheria;   Tetanus;   Polio;   Pertussis;   Haemophilus Infections
Intervention: Biological: Diphteria/Tetanus/Polio/Acellular Pertussis/Hib vaccine
28 Completed Immune Response & Safety of GSK Biologicals' Mencevax™ ACWY in Subjects Primed in the DTPW-HBV=HIB-MENAC-TT-011 Study
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Hib Disease;   Neisseria Meningitidis Serogroup Diseases
Interventions: Biological: Tritanrix™- HepB;   Biological: Hiberix™;   Biological: Mencevax™ ACWY
29 Active, not recruiting A Trial to Evaluate the Safety and Immunogenicity of ADACEL Vaccine in Persons 65 Years of Age and Older
Conditions: Pertussis;   Tetanus;   Diphtheria
Interventions: Biological: Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed;   Biological: Tetanus and Diphtheria Toxoids Adsorbed
30 Active, not recruiting Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Poliomyelitis
Interventions: Biological: DTaP-IPV-HB-PRP~T vaccine;   Biological: DTaP-IPV-HB-PRP~T vaccine;   Biological: DTaP-IPV-HB-PRP~T vaccine;   Biological: DTaP-HBV-IPV vaccine
31 Active, not recruiting Post-Licensure, Modified Double-Blind, Multi-Center Study Evaluating Safety and Immunogenicity of ADACEL and BOOSTRIX
Conditions: Pertussis;   Tetanus;   Diphtheria
Interventions: Biological: ADACEL®:;   Biological: BOOSTRIX®
32 Completed Study of New Formulation of Infanrix Hexa Administered as a Booster Dose to 18-23 Months Old Children
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Poliomyelitis;   Haemophilus Influenzae Type b Disease
Intervention: Biological: Infanrix hexa
33 Completed Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination
Conditions: Diphtheria;   Tetanus;   Pertussis
Intervention: Biological: Boostrix
34 Active, not recruiting Immunogenicity and Safety of Pentaxim in South African Infants
Conditions: Diphtheria;   Tetanus;   Haemophilus Infections;   Pertussis;   Poliomyelitis
Intervention: Biological: Diphtheria, Tetanus, Polio, Acellular Pertussis and Hib
35 Completed Retrospective Survey of Safety of Fourth Dose Pentacel™ in Children
Conditions: Diphtheria;   Pertussis;   Haemophilus Infection;   Tetanus;   Polio
Intervention:
36 Active, not recruiting Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months
Conditions: Diphtheria;   Tetanus;   Haemophilus Influenzae Type B;   Pertussis;   Poliomyelitis
Interventions: Biological: Diphtheria, Tetanus, Polio, Acellular Pertussis and Hib;   Biological: Diphtheria, Tetanus, Polio, Acellular Pertussis and Hib;   Biological: Diphtheria, Tetanus, & Acellular Pertussis Combined, Absorbed
37 Completed Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine
Conditions: Diphtheria;   Tetanus;   Whooping Cough;   Polio;   Haemophilus Influenzae Type B
Interventions: Biological: DAPTACEL® (Diphtheria and Tetanus Toxoids and Acellular Pertussis vaccine);   Biological: DTaP-IPV/Hib
38 Active, not recruiting Study Comparing a DTaP HB PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy Infants
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Influenza
Interventions: Biological: DTaP-HB-PRP~T combined vaccine;   Biological: Tritanrix-HepB/Hib™ vaccine
39 Active, not recruiting Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Haemophilus Infections
Interventions: Biological: DTaP-HB-PRP~T vaccine;   Biological: Tritanrix-HepB/Hib™
40 Completed Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL®
Conditions: Diphtheria;   Tetanus;   Pertussis
Interventions: Biological: DTaP;   Biological: DTaP

Previous Page (1-20) Studies Shown (21-40) Next (41-60)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services